a drug indicated in the off-label use of reducing estrogens (in particular and more importantly, estradiol) in men. Excess breast cancer arimidex in men breast cancer arimidex cause benign prostatic hyperplasia, gynecomastia, and symptoms of hypogonadism. Some breast cancer arimidex and body builders will also use anastrozole as a part of their steroid cycle to reduce and.

(U.S.)Routes oralAnastrozole (INN, trade name: Arimidex®) is a drug indicated in the treatment of the ATAC (Arimidex, Tamoxifen, Alone or breast cancer arimidex Combination) breast cancer arimidex after completion of 5 years' adjuvant treatment for breast cancer arimidex cancer". Lancet 365 (9453): 60-2. doi:10.1016/S0140-6736(04)17666-6. PMID 15639680.[edit] External linksArimidex.com - Information about Arimidex breast cancer arimidex breast cancer[hide]v • d • eSex hormones and related agents (primarily G03, also L02, H01C) - human endogenous breast cancer arimidex CAPSProgestogens:(receptor) PROGESTERONE,Dienogest, Desogestrel, Drospirenone, Dydrogesterone, Ethisterone, Etonogestrel, Ethynodiol diacetate, Gestodene, breast cancer arimidex Levonorgestrel, Lynestrenol, Medroxyprogesterone, Megestrol, Norelgestromin, Norethisterone, Norethynodrel, Norgestimate, Norgestrel, Norgestrienone, TiboloneSelective progesterone receptor modulator: Afimoxifene, Bazedoxifene, Clomifene, Fulvestrant, Lasofoxifene, Raloxifene, Tamoxifen, ToremifeneAromatase inhibitor: Aminogluthetimide, Anastrozole, Exemestane.

dataFormula C17H19N5Mol. mass 293.366 g/molSMILES eMolecules & PubChemPharmacokinetic dataBioavailability 83-85%Protein binding.